MyFinsight
Home
Blog
About
Other, net
-$1,019M
(-517.62%↓ Y/Y)
Net earnings
$928M
(-47.84%↓ Y/Y)
Amortization of intangible
assets
$658M
(56.67%↑ Y/Y)
Depreciation
$402M
(12.61%↑ Y/Y)
Share-based compensation
$168M
(18.31%↑ Y/Y)
Net cash from
operating activities
$2,488M
(21.54%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$4M
(-92.16%↓ Y/Y)
Canceled cashflow
$687M
Net increase
(decrease) in cash and cash...
-$1,699M
(-505.49%↓ Y/Y)
Canceled cashflow
$2,492M
Net borrowings
(repayments) of short-term...
$64M
(500.00%↑ Y/Y)
Proceeds from stock
options exercised
$3M
(-91.43%↓ Y/Y)
Other
-$14M
(-600.00%↓ Y/Y)
Trade receivables
$386M
(-5.85%↓ Y/Y)
Inventories
$301M
(10133.33%↑ Y/Y)
Net cash from (used
in) financing...
-$3,518M
(-220.69%↓ Y/Y)
Canceled cashflow
$67M
Net cash from (used
in) investing...
-$673M
(-15.64%↓ Y/Y)
Canceled cashflow
$14M
Repayments of long-term
debt
$1,405M
(140400.00%↑ Y/Y)
Dividends paid
$1,102M
(7.09%↑ Y/Y)
Purchases of common shares
$1,045M
(17316.67%↑ Y/Y)
Proceeds from issuance of
long-term debt
-$33M
(-1750.00%↓ Y/Y)
Acquisitions of property and
equipment
$497M
(-1.00%↓ Y/Y)
Acquisitions of businesses
and technologies,...
$164M
(446.67%↑ Y/Y)
Sales (purchases) of
other investment...
$26M
(-50.00%↓ Y/Y)
Back
Back
Cash Flow
Abbott_Laboratories_logo-svg
ABBOTT LABORATORIES (ABT)
Abbott_Laboratories_logo-svg
ABBOTT LABORATORIES (ABT)
source: myfinsight.com